Nabriva Therapeutics Plc (NBRV) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nabriva Therapeutics Plc  (NASDAQ: NBRV)


Nabriva Therapeutics Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NBRV Gross Profit Margin (Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
Y / Y Revenue Change -75.6 %
Seq. Revenue Change -70.45 %
Revenue In Millions $2.24
Gross Profit Margin -304.55 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-6.83
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2023 Gross Profit Margin
Nabriva Therapeutics Plc recorded Gross Loss compared to Gross Profit achieved in the preceding quarter.


Observing second quarter 2023 results within Major Pharmaceutical Preparations industry Nabriva Therapeutics Plc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to , from total ranking in the previous quarter at 2208.
Learn about Gross Margin
NBRV's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
99.78 % 67.3 % 24.44 %
(Sep 30 2019)   (Jun 30 2020)




Other Gross Profit Margin Profitability Ratios
NBRV's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NBRV's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NBRV's Competitors
Gross Profit Margin Profit Margin for Nabriva Therapeutics Plc's Suppliers
Gross Profit Margin Profit Margin for NBRV's Customers

You may also want to know
NBRV's Annual Growth Rates NBRV's Profitability Ratios NBRV's Asset Turnover Ratio NBRV's Dividend Growth
NBRV's Roe NBRV's Valuation Ratios NBRV's Financial Strength Ratios NBRV's Gross Profit Growth
NBRV's Roa NBRV's Inventory Turnover Ratio NBRV's Growth Rates NBRV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.